Aditxt (ADTX) Cash & Current Investments (2019 - 2026)
Aditxt (ADTX) recorded quarterly Cash & Current Investments of $268852.0 in Q1 2026, down 91.59% quarter-over-quarter from $3.2 million in Q4 2025, and down 43.57% on a YoY basis from $476416.0 in Q1 2025.
Aditxt (ADTX) Cash & Current Investments (2019 - 2026) Analysis & Trends
Aditxt's Cash & Current Investments history runs 8 years deep, the most recent figure standing at $268852.0 for Q1 2026.
- In Q1 2026, Cash & Current Investments fell 43.57% year-over-year to $268852.0; the TTM figure through Mar 2026 stood at $268852.0 (down 43.57% YoY), while the FY2025 annual figure was $3.2 million, up 283.97% from the prior year.
- Cash & Current Investments was $268852.0 for Q1 2026 at Aditxt, down from $3.2 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $9.2 million in Q3 2022 to a low of $88671.0 in Q1 2024.
- Historically, Cash & Current Investments has averaged $1.3 million across 5 years, with a median of $358596.0 in 2024.
- The sharpest annual moves came in 2023 and 2024: Cash & Current Investments sank 96.49% in 2023, then surged 757.89% in 2024.
- A 5-year view of Cash & Current Investments shows it stood at $2.8 million in 2022, then tumbled by 96.49% to $97102.0 in 2023, then surged by 757.89% to $833031.0 in 2024, then jumped by 283.97% to $3.2 million in 2025, then sank by 91.59% to $268852.0 in 2026.
- The last three Cash & Current Investments figures came in at $268852.0 (Q1 2026), $3.2 million (Q4 2025), and $163041.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.13 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | 268,852.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 268,852.00 |
| Dec 31, 2025 | 3.20 Mn |
| Sep 30, 2025 | 163,041.00 |
| Jun 30, 2025 | 323,679.00 |
| Mar 31, 2025 | 476,416.00 |
| Dec 31, 2024 | 833,031.00 |
| Sep 30, 2024 | 358,596.00 |
| Jun 30, 2024 | 91,223.00 |
| Mar 31, 2024 | 88,671.00 |
| Dec 31, 2023 | 97,102.00 |
| Sep 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 95,953.00 |
| Mar 31, 2023 | 302,509.00 |
| Dec 31, 2022 | 2.77 Mn |
| Sep 30, 2022 | 9.24 Mn |
| Jun 30, 2022 | 803,971.00 |
| Mar 31, 2022 | 2.12 Mn |
| Dec 31, 2021 | 7.87 Mn |
| Sep 30, 2021 | 5.47 Mn |
| Jun 30, 2021 | 8.61 Mn |